Patient activation measure

1. Patient activation measure has no effect on HbA1c in humans (1.9%; IQR: -1.9 to 4.7, p=0.601).

   “Median changes in BMI (0%; IQR: -3.1 to 4.0) and HbA1c (1.9%; IQR: -1.9 to 4.7) were not associated with baseline activation level (BMI p=0.707; HbA1c p=0.601).”

   Human trialhistory of gestational diabetes mellitus12 monthsfemalesn = 92

   Does Patient Activation Correlate with Lifestyle Change Program Study Completion in Patients with a History of Gestational Diabetes Mellitus?

   ADA Scientific Sessions 2025 abstract·Jun 13, 2025

More on HbA1c

1. Patient activation measure has no effect on body mass index in humans (0%; IQR: -3.1 to 4.0, p=0.707).

   “Median changes in BMI (0%; IQR: -3.1 to 4.0) and HbA1c (1.9%; IQR: -1.9 to 4.7) were not associated with baseline activation level (BMI p=0.707; HbA1c p=0.601).”

   Human trialhistory of gestational diabetes mellitus12 monthsfemalesn = 92

   Does Patient Activation Correlate with Lifestyle Change Program Study Completion in Patients with a History of Gestational Diabetes Mellitus?

   ADA Scientific Sessions 2025 abstract·Jun 13, 2025

More on Body mass index

1. Patient activation measure has no effect on program completion in humans (p=0.290).

   “Study discontinuation did not vary by baseline PAM score (p=0.290).”

   Human trialhistory of gestational diabetes mellitus12 monthsfemalesn = 92

   Does Patient Activation Correlate with Lifestyle Change Program Study Completion in Patients with a History of Gestational Diabetes Mellitus?

   ADA Scientific Sessions 2025 abstract·Jun 13, 2025